Roth Capital Cuts Earnings Estimates for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZFree Report) – Stock analysts at Roth Capital reduced their FY2025 EPS estimates for shares of Core Scientific in a research note issued on Tuesday, January 7th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.30) per share for the year, down from their previous forecast of ($0.29). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

Other analysts have also recently issued reports about the company. Roth Mkm started coverage on Core Scientific in a report on Friday, November 15th. They set a “buy” rating and a $25.50 price objective for the company. BTIG Research raised their price objective on shares of Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, December 16th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $17.00 target price on shares of Core Scientific in a report on Thursday, November 7th. Macquarie increased their price target on Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. Finally, Needham & Company LLC lifted their price objective on Core Scientific from $17.00 to $18.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Thirteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Core Scientific currently has an average rating of “Buy” and a consensus target price of $18.46.

Read Our Latest Stock Analysis on Core Scientific

Core Scientific Price Performance

CORZ stock opened at $14.05 on Thursday. The stock has a market capitalization of $3.92 billion and a PE ratio of -2.60. The company has a 50 day moving average price of $15.62 and a 200 day moving average price of $12.56. Core Scientific has a fifty-two week low of $2.61 and a fifty-two week high of $18.63.

Insiders Place Their Bets

In other Core Scientific news, CEO Adam Taylor Sullivan sold 88,380 shares of Core Scientific stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,258,531.20. Following the sale, the chief executive officer now owns 4,128,505 shares of the company’s stock, valued at $58,789,911.20. This trade represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Todd M. Duchene sold 25,000 shares of the business’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.10, for a total value of $427,500.00. Following the completion of the sale, the insider now owns 1,661,474 shares in the company, valued at approximately $28,411,205.40. This trade represents a 1.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 348,241 shares of company stock worth $5,436,802. Company insiders own 32.00% of the company’s stock.

Institutional Investors Weigh In On Core Scientific

Hedge funds and other institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its position in Core Scientific by 48.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock worth $5,192,000 after acquiring an additional 142,068 shares during the last quarter. Sanctuary Advisors LLC boosted its holdings in Core Scientific by 130.1% during the third quarter. Sanctuary Advisors LLC now owns 34,527 shares of the company’s stock worth $409,000 after purchasing an additional 19,522 shares during the last quarter. Neo Ivy Capital Management bought a new position in Core Scientific in the third quarter valued at $194,000. Geode Capital Management LLC increased its stake in Core Scientific by 26.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company’s stock valued at $62,594,000 after buying an additional 1,113,285 shares during the last quarter. Finally, Sender Co & Partners Inc. acquired a new stake in Core Scientific in the 3rd quarter valued at $2,426,000.

About Core Scientific

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

See Also

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.